MELK and neoplasm: OTSSP167 is a selective small‐molecule inhibitor against MELK, developed in 2012 and has been verified to inhibit proliferation in several tumor cells from different sources.25, 26 OTSSP167 has been used in healthy volunteers to assess its safety in Australia.